03.12.2012 Views

strategic-management

strategic-management

strategic-management

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

160 PART 2 • STRATEGY FORMULATION<br />

TABLE 5-9 Some Large Mergers Completed Globally in 2009<br />

Acquiring Firm Acquired Firm<br />

Price<br />

(in $Billions)<br />

InBev Anheuser-Busch Cos. 52.000<br />

Bank of America Corp. Merrill Lynch & Co. 50.0<br />

Wells Fargo & Co. Wachovia Corp. 15.1<br />

Delta Air Lines Northwest Airlines Corp. 2.600<br />

AT&T Centennial Communications 0.937<br />

Johnson & Johnson Mentor Corp. 1.070<br />

King Pharmaceuticals Inc. Alpharma Inc. 1.600<br />

CenturyTel Embark 5.000<br />

Corp. Similarly, Tenaris SA, based in Luxembourg and the world’s biggest maker of steel<br />

tubes used in oil exploration and production, recently acquired rival Hydril Company,<br />

based in Houston, Texas.<br />

Table 5-9 shows some mergers and acquisitions completed in 2009. There are many<br />

potential benefits of merging with or acquiring another firm, as indicated in Table 5-10.<br />

Johnson & Johnson’s (J&J) recent acquisition of Mentor for $1.07 billion was a<br />

hefty 92 percent premium over Mentor’s closing price before the deal was announced,<br />

but was 23 percent below another widely used evaluation method that was number of<br />

shares outstanding times the target firm’s 52-week stock price high. Many companies are<br />

being forced to sell under duress, so firms with a lot of cash such as J&J and Apple can<br />

pick up deals of a lifetime these days. J&J had $14 billion in cash on hand in 2009 when<br />

it purchased Omrix Pharmaceuticals for $438 million. Then the largest health-care<br />

company in the world, J&J purchased Mentor for $1.07 billion in cash. Bristol-Myers<br />

Squibb’s CEO James Cornelius recently said that company is looking to do six or seven<br />

additional acquisitions or partnerships with the $9 billion in cash it has on hand to bolster<br />

its drug pipeline.<br />

The volume of mergers completed annually worldwide is growing dramatically and<br />

exceeds $1 trillion. There are annually more than 10,000 mergers in the United States that<br />

total more than $700 billion. The proliferation of mergers is fueled by companies’ drive<br />

for market share, efficiency, and pricing power, as well as by globalization, the need<br />

for greater economies of scale, reduced regulation and antitrust concerns, the Internet, and<br />

e-commerce.<br />

A leveraged buyout (LBO) occurs when a corporation’s shareholders are bought<br />

(hence buyout) by the company’s <strong>management</strong> and other private investors using borrowed<br />

funds (hence leverage). 36 Besides trying to avoid a hostile takeover, other reasons for initiating<br />

an LBO are senior <strong>management</strong> decisions that particular divisions do not fit into an<br />

overall corporate strategy or must be sold to raise cash, or receipt of an attractive offering<br />

price. An LBO takes a corporation private.<br />

TABLE 5-10 Potential Benefits of Merging with or Acquiring<br />

Another Firm<br />

• To provide improved capacity utilization<br />

• To make better use of the existing sales force<br />

• To reduce managerial staff<br />

• To gain economies of scale<br />

• To smooth out seasonal trends in sales<br />

• To gain access to new suppliers, distributors, customers, products, and creditors<br />

• To gain new technology<br />

• To reduce tax obligations

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!